InnoMed Technologies Adds Viasys to Patent Lawsuit

BOCA RATON, Fla.--(BUSINESS WIRE)-- March 18, 2004 InnoMed Technologies announced today that the United States District Court in Orlando, Florida has determined that it has jurisdiction over Innomed's claims for patent infringement against the manufacturer of the Spiritus nasal interface, Worldwide Medical Technologies, Inc. InnoMed has sued Worldwide and its former distributor, Viasys Healthcare, Inc., (VAS-NYSE) for the infringement of U.S. Patent 6,595, 215. The patent is directed, among other things, to a ventilation interface for sleep apnea therapy. The interface includes a pair of nasal inserts adapted to form a seal against the nares of a patient's nose.

'The Court's ruling on jurisdiction has now cleared the way to proceed forward on our suit to protect Innomed's Nasal-Aire products from infringement', said Shara Hernandez, President of InnoMed Technologies, Inc. 'We have a number of issued patents and patents pending,' Ms. Hernandez stated, 'and we intend to protect our intellectual property rights in our new CPAP devices.'

InnoMed designs, manufactures and markets the innovative Nasal-Aire, Nasal-Aire II and the Nasal-Aire II Critical Care. Independent clinical trials have shown that when patients are given a choice between using the Nasal-Aire or the three leading competitive masks, manufactured by Resmed, Inc. (NYSE:RMD), Respironics (Nasdaq:RESP), and Mallinckrodt, 98% of the time Nasal-Aire was chosen.

InnoMed Technologies, Inc., is a research-oriented, privately held, 21st Century medical technologies company. The company is poised to bring new and more effective medical products and devices to the public through a medical development and engineering team, as well as acquisitions of other medical related companies. InnoMed holds several patents and has several patents pending. More information regarding InnoMed Technologies is available at http://www.innomedinc.com.

A Private Securities Reform Act of 1995 provides a 'safe harbor' for forward-looking statements. Certain information included in this press release (as well as information included in written statements to be made) contain statements that are forward-looking, such as those relating to consummation of the transaction, anticipated future revenue of the Company, and success of current public offerings. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ materially from those expressed in any forward looking statements.